Genetic predictors of AML outcome get more specific
Advanced profiling of gene mutations in acute myeloid leukemia could potentially be used to help predict prognosis and guide treatment decisions.
Diagnosis & Disease Information
Specific Mutations in AML Affect Response to Therapy
Also, bone marrow cells in myelodysplastic syndromes, secondary AML are clonal.
Ten-Year CML Survival Estimate of 68 Percent With Imatinib
Good long-term survival for chronic myeloid leukemia after failed interferon alpha treatment.
Gleevec wins wider approval for use in GI cancer
Gleevec (imatinib mesylate) has been granted regular approval by the FDA for use in adults following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST).
High rate of leukemia in elderly may be due to stem cell aging
Hematopoietic stem cells from healthy persons older than 65 years make fewer immunoprotective lymphocytes than do stem cells from healthy persons aged 20 to 35 years.
- Loading...
Loading...
Loading... 
Loading...